Evidence map›Paper›PMID 40622649›Full record

ReviewProbiotics and antimicrobial proteins2026

Scaling Up Postbiotics Production: A Prospective Review of Processes and Health Benefits.

Shree Kumari G R, Mohanasrinivasan V

Abstract readReview
PubMed Publisher
In one paragraph

Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Emerging Nonthermal Technologies for the Production of Postbiotics.Comprehensive reviews in food science and food safety · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shree Kumari G RSchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India.ORCID http://orcid.org/0000-0003-4833-1856
Mohanasrinivasan VSchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India. v.mohan@vit.ac.in.ORCID http://orcid.org/0000-0001-7638-351X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Postbiotics are bioactive compounds produced by probiotic bacteria that have taken the spotlight for their significant health benefits. These postbiotics include digestive enzymes, short-chain fatty acids, cell wall components, bacteriocins, exopolysaccharides, and vitamins. Among many health benefits, postbiotics possess immunomodulatory effect; cholesterol regulation; antimicrobial, antioxidant, and anti-inflammatory properties; enhanced gut health; and reduced risk of cardiovascular diseases, although the mechanism of action of these health benefits is yet to be fully understood. Forecast indicates a rising industrial demand for postbiotic production. This review summarizes the tools and techniques employed in optimizing postbiotic production that aid in overcoming those challenges that currently interrupt industrial scale-up. Plackett-Burman design, response surface methodology (RSM), Taguchi method, and central composite design (CCD) are significant tools for optimizing postbiotic production conditions. Molecular techniques including genetic engineering, synthetic biology tools such as CRISPR-Cas9, and metabolic engineering are potential techniques to enhance postbiotic production. Despite these advancements, challenges remain in industrial scale-up (stability, quality, yield, and consistency). Understanding the correlation between high cell density and postbiotic yield is crucial for industrial scale-up and optimized production. However, further in-depth research is in demand for industrial production of postbiotics. This review would benefit researchers exploring the mechanism of action and industrial production of postbiotics.

Indexed as

BacteriaProbioticsHumansCardiovascular healthGut healthGut microbiomePostbiotic productionPostbioticsShort-chain fatty acids

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.